View Article

Abstract

Simple, fast, and reliable methods were developed for the simultaneous estimation of Drotaverine hydrochloride and Omeprazole in combined dosage form. The analysis was performed using Reverse Phase High Performance Liquid Chromatography (RP-HPLC) and UV spectrophotometric methods. In the RP-HPLC method, both drugs were separated using a C18 column with a suitable mobile phase and detected at a selected wavelength. The UV method was based on measuring the absorbance of both drugs at their respective wavelengths. The developed methods were validated according to ICH guidelines for accuracy, precision, linearity, and specificity. Both drugs showed good linearity in the selected concentration range, with acceptable recovery and low variation in results. The proposed methods were successfully used for routine analysis and quality control of Drotaverine and Omeprazole in combined pharmaceutical dosage forms.

Keywords

Drotaverine hydrochloride, Omeprazole, RP-HPLC, UV spectrophotometry, Method validation

Introduction

× Popup Image

Analytical Chemistry is a measurement of science consisting of a set of powerful ideas and methods that are useful in all fields of science and medicine. It seeks ever-improved means of measuring the chemical composition of natural and artificial materials. This branch of chemistry, which is both theoretical and practical science, is practiced in many laboratories in many diverse ways while the analytical method is a specific application of a technique to solve an analytical problem. Methods of analysis are routinely developed, improved, validated, collaboratively studied, and applied. The discipline of analytical chemistry consists of qualitative and quantitative analysis.1

CHROMATOGRAPHY:2

The term ‘Chromatography’ covers those processes aimed at the separation of the various species of a mixture based on their distribution characteristics between a stationary and a mobile phase.

This may be regarded as an analytical technique employed for the purification and separation of organic and inorganic substances. There are various advanced chromatographic techniques, widely used for the estimation of multi component drugs in their formulations. The various chromatographic techniques are.

  • High Performance Liquid Chromatography
  • High-Performance Thin Layer Chromatography
  • Gas Chromatography

DRUG PROFILE

Drotaverine:27

Name

Drotaverine

Description

Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4 and has no anticholinergic effects. Drotaverine has been shown to possess dose-dependent analgesic effects in animal models. One small study has shown drotaverine tobe eliminated mainly non-renally.

Structure

Synonyms

Drotaverin

Salts

Not Available

International/ Other Brands

Drotin / No-Spa(Sanofi-Aventis)/Taverin

Chemical Formula

C24H31NO4

IUPAC Name

(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-1,2,3,4- tetrahydroisoquinoline

Pharmacology

 

Indication

Used in the treatment of functional bowel disorders and alleviating pain in renal colic.

Pharmacodynamics

Drotaverine is a spasmolytic agent by inhibiting PDE4 in smooth muscle cells.

Half life

7 to 12 hours

Omeprazole:38

Chemical structure

Chemical name

(RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d] imidazole

Molecular formula

C17H19N3O3S

Molecular weight

345.4 g/mol

Drug type

Approved drug

Therapeutic category

Proton pump inhibitor

Indications

For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastrointestinal bleeds with NSAID use.

Half life

1-12hrs.

CHARACTERIZATION OF DROTAVERINE & OMEPRAZOLE39,40

  • Solubility of Drotaverine: The solubility of the drug sample was determined according to I.P.1996.
  • Solubility of Omeprazole: The solubility of the drug sample was determined according to I.P. 1996.

RESULT AND DISCUSSION:

Drotaverine was found to be insoluble in water and soluble in acetonitrile & methanol. Omeprazole was found to be soluble in water and freely frsoluble in methanol & acetonitrile.

Method Development and Its Validation for Simultaneous Estimation of Drotaverine & Omeprazole by Rp-HPLC In Combination Tablet Dosage Form

  • Selection of wavelength

The λmax of the two ingredients i.e. Drotaverine & Omeprazole, were found to be 277 nm and 307 nm respectively in methanol as solvent system. The isosbestic point for the drugs were found at 284 nm.

  • Preparation of standard solution of Drotaverine:

10 mg of Drotaverine was weighed accurately and transferred into a 100 ml volumetric flask. About 10 ml of HPLC- grade methanol was added and sonicated to dissolve. The volume was made up to the mark with the same solvent. The final solution contained about 100 μg/ml of Drotaverine.

  • Preparation of standard solution of Omeprazole:

10 mg of Omeprazole was weighed accurately and transferred into a 100 ml volumetric flask. About 10 ml of HPLC- grade methanol was added and sonicated to dissolve. The volume was made up to the mark with the same solvent. The final solution contained about 100 μg/ml of Omeprazole.

Fig: 3 Drotaverine

Fig: 4 Omeprazole

Preparation of mix Standard solution of Drotaverine & Omeprazole:

Accurately weighed 100 mg of Drotaverine and 100 mg of Omeprazole were transferred to 100 ml volumetric flask. About 40 ml of mobile phase was added and sonicated to dissolve. The volume was made up to mark with same solvent. Then 2 ml of the above solution was diluted to 100 ml with the solvent system. The resultant solution was filtered through a 0.45 ?m membrane filter and degassed under an ultrasonic bath before use. Several working standard solutions are prepared from the above standard solution by serial dilution technique.

Initialization of the instrument:

The HPLC instrument was switched on. The column was washed with HPLC water for45 minutes. The column was then saturated with mobile phase for 45 min. The mobile phase was run to find the peaks. After 20 minutes the standard drug solution was injected in HPLC.

Different chromatographic conditions used and their Optimizations.

The different HPLC chromatographic conditions were used to find out the optimum chromatographic condition for best elution of drugs.

Trial -1

Table: 7 Chromatographic conditions1 (Trial-1)

Mobile phase

Water: CAN (20:80)

Wavelength

273nm

Flowrate

1.0 ml/ min.

Run time

10 min.

Column

Develosil ODS HG-5 RP C18, 5?m, 15cmx4.6mm i.d.

Trial-2

No peaks were found. Hence chromatogram was not acceptable.

Table: 8 Chromatographic conditions 2 (Trial-2)

Mobile phase

Water : Methanol (20:80)

Wavelength

307 nm

Flowrate

1.0 ml/ min.

Run time

10 min.

Column

Develosil ODS HG-5 RP C18, 5?m, 15cmx4.6mmi.d.

Trial-3

Only one peak was observed, resolution were not there. Hence chromatogram was not acceptable.

Table: 9 Chromatographic conditions 3 (Trial-3)

Mobile phase

Buffer : acetonitrile (40:60)

Wavelength

307 nm

Flowrate

1.0 ml/ min.

Run time

10 min.

Column

Develosil ODS HG-5 RP C18, 5?m, 15cmx4.6mmi.d.

Trial-4

Peak separation was not good, and a third peak was found. Hence chromatogram was not acceptable.

Table: 10 Chromatographic conditions 4 (Trial-4)

Mobile phase

Potassium dihydrogen phosphate buffer + Dipotassium hydrogen phosphate (0.02M,pH3.0) : acetonitrile (45:55)

Wavelength

307 nm

Flowrate

1.0 ml/ min.

Run time

10 min.

Column

Develosil ODS HG -5RP C18,5?m, 15cmx4.6mmi.d.

The chromatogram obtained after condition 4, Typical chromatogram of DROTAVERINE (RT=2.67 min) and OMEPRAZOLE (RT= 4.95 min).

RESULT AND DISCUSSION:

Here resolution was good, theoretical plate count and symmetry was appropriate. Also, no unwanted little peaks were seen between two peaks. Hence it was acceptable.

Optimized Method:

The selected and optimized mobile phase was acetonitrile : potassium dihydrogen phosphate buffer (0.02M, pH 3.0) (55:45v/v) and conditions optimized were : flow rate (1.0 ml/minute), wavelength (273 nm), Run time was 20 min. Here the peaks were separated and showed better resolution, theoretical plate count and symmetry. The proposed chromatographic conditions were found appropriate for the quantitative determination of the drugs.

Preparation of mobile phase:

Mobile phase was prepared by taking acetonitrile: potassium dihydrogen phosphate buffer (0.02M, pH 3.0) (55:45v/v). Mobile phase was filtered through 0.45 ?m membrane filter and degassed under ultrasonic bath prior to use. The mobile phase was pumped through the column at a flow rate of 1.0 ml/min.

Running the standard solution of Drotaverine:

2 ml of stock solution prepared as mentioned under section 4.5.2was pipette out into a 10 ml volumetric flask. The volume was made up to the mark with mobile phase. The solution was filtered through the 0.45 ?m membrane filter and degassed under ultrasonic bath prior to use. The solution was injected into the HPLC system.

Fig: 6 Chromatogram of Drotaverine

Result & Discussion: Retention time was found to be 2.67 min.

Running the standard solution of Omeprazole:

4 ml of stock solution prepared as mentioned under section 4.5.3 was pipetted into a 10 ml volumetric flask. The volume was made up to the mark with methanol. The solution was filtered through the 0.45 ?m membrane filter and degassed under ultrasonic bath prior to use. The solution was injected into the HPLC system. The chromatogram obtained is shown in figure 7.

Fig:7 Chromatogram of Omeprazole

Result & Discussion: Retention time was found to be 4.97 min.

Result & Discussion: The HPLC system was set with the optimized chromatographic conditions to run the standard solution of Drotaverine and Omeprazole for 10 min. The retention time were found to be2.69 min and 4.97 min respectively.

  • Linearity and Range

Result & Discussion: Linearity range was found to be 0-140 µg/ml for Drotaverine. The correlation coefficient was found to be 0.995, the slope was found to be 8031 and intercept was found to be 10243 for Drotaverine. 

Linearity range was found to be 5-100 µg/ml for Omeprazole. The correlation coefficient was found to be 0.998, the slope was found to be 38873 and intercept was found to be 13606 for Omeprrazole.

  • Accuracy:

Result & Discussion: The mean recoveries were found to be 98.976, 99.54, 99.57 % for Omeprazole and 98.94, 99.76, 99.31% for Drotaverine The limit for mean % recovery is 95-105% and as both the values are within the limit, hence it can be said that the proposed method was accurate.

  • Precision:

Result & Discussion: The repeatability study which was conducted on the solution having the concentration of about 20mg/ml for Drotaverine and 40mg/ml for Omeprazole (n =5) showed a RSD of 0.07684% for Drotaverine and 1.203503% for Omeprazole. It was concluded that the analytical technique showed good repeatability.

  • Intermediate precision

Result and discussion: Intraday and interday studies show that the mean RSD (%) was found to be within acceptance limit (≤2%), so it was concluded that there was no significant difference for the assay, which was tested within day and between days. Hence, method at selected wavelength was found to be precise.

Limit of detection and limit of quantification

The detection limit (LOD) and quantitation limit (LOQ) may be expressed as:

L.O.D. = 3.3(SD/S).

L.O.Q. = 10(SD/S)

Where, SD = Standard deviation of the response

             S = Slope of the calibration curve

Result & Discussion

The LOD was found to be 0.32mg/ml and 1.44mg/ml and LOQ was found to be 0.96mg/ml and 4.32mg/ml for Drotaverine & Omeprazole respectively which represents that sensitivity of the method is high.

ASSAY OF DROTAVERINE & OMEPRAZOLE INDOSAGE FORM:

Assay was performed as described in previous chapter. Results obtained are tabulated below:

Table :17 Assay ofDrotaverine &Omeprazole Tablets

Brand name of tablets

Labelled amount of Drug (mg) Drotaverine &Omeprazole

Mean (±SD) amount (mg) found by the proposed method (n=6)

Mean (± SD) Assay (n = 6)

Ranispas – DV (Mankind Pharmaceuticals Pvt. Ltd.)

10, 40

10.04 (±0.13)

40.53 (±0.09)

100.40 (±0.39)

101.325 (±0.42)

The assay of Synasmaaxtablets containing Drotaverine was found to be 101.325% Omeprazole was found to be 100.40%.

SUMMARY

To develop a precise, linear, specific RP-HPLC method for analysis of Drotaverine & Omeprazole different chromatographic conditions were applied & the results observed are presented in the thesis.

Isocratic elution is simple, requires only one pump & flat baseline separation for easy and reproducible results. So, it was preferred for the current study over gradient elution.

In case of RP-HPLC various columns are available, but here develo Sil, C-18, V size (150mm*4.6mmØ) column was preferred because using this column peak shape, resolution and absorbance were good.

Mobile phase & diluent for preparation of various samples were finalized after studying the solubility of API in different solvents of our disposal (methanol, acetonitrile, dichloromethane, water, 0.1N NaOH, 0.1NHCl). Drotaverine was found to be insoluble in water and soluble in acetonitrile & methanol. Omeprazole was found to be soluble in water and freely soluble in methanol & acetonitrile.

Detection wavelength was selected after scanning the standard solution of drug over 200 to 800nm. From the U.V spectrum of Drotaverine & Omeprazole it is evident that most of the HPLC work can be accomplished in the   wavelength range of 215-290 nm conveniently. Further, a flow rate of 1.0 ml/min & an injection volume of 20 µl were found to be the best analysis.

The result shows the developed method is yet another suitable method for assay which can help in the analysis of Drotaverine&Omeprazole in different formulations.

Final Result & Discussion: The selected and optimized mobile phase was acetonitrile: potassium dihydrogen phosphate buffer (0.02M, pH 3.0) (55:45v/v) and conditions optimized were: flow rate (1.0 ml/minute), wavelength (273 nm), Run time was 20 min. Here the peaks were separated and showed better resolution, theoretical plate count and symmetry. The proposed chromatographic conditions were found appropriate for the quantitative determination of the drugs.

CONCLUSION

A sensitive & selective stability indicting RP-HPLC method has been developed & validated for the analysis of Drotaverine & Omeprazole API.

Based on peak purity results, obtained from the analysis of samples using described method, it can be concluded that the absence of co-eluting peak along with the main peak of Drotaverine & Omeprazole indicated that the developed method is specific for the estimation of Drotaverine & Omeprazole.

Further the proposed RP-HPLC method has excellent sensitivity, precision and reproducibility.

Here resolution was good, theoretical plate count and symmetry were appropriate. Also, no unwanted little peaks were seen between two peaks. Hence it was acceptable.

REFERENCES

  1. Beckett H., Stenlake J.B., “Practical Pharmaceutical Chemistry.”, C.B.S. Publications, 4th Edition, 1
  2. Vijay Malik, “Drugs And Cosmetics Act.”, Eastern Book Company Lucknow, 16th Edition, 5.
  3. Willard H. H., Merit L.L., Dean F.A., And Settle F.A., “Instrumental Methods Of Analysis.”, C.B. S. Publishers, New Delhi, 7th Edition, 2002, 580-613
  4. Skoog D.A., Holler F.J., Nieman T.A., “ Principles Of Instrumental Analysis.”, 5th Edition, 2005, 733-738.
  5. Sharma b.k., “instrumental methods of chemical analysis.”, goel publishing house, meerut, 24th edition, 2005, c-210-215..
  6. Michael e., schartz s., krull., “analytical method development and validation.”, 2004, 25-46
  7. Lloyd R. Snyder., Joseph J. Kirkland., Joseph L. Glajesh., “Practical Hplc Method Development.”, 2nd Edition, 1997, 1-14.
  8. Cims – 2006, Current Index Of Medical Specialities, Pp.172 – 174.
  9. Alfred Goodman Gilman, Joel G.Hardaman, Lee E.Limbird, 2001, Goodman Gilman’s The Pharmacological Bases Of Therapeutics 10th Edn., Pp. 994 – 995.
  10. Manoj, Shanmugapandiyan.P And Anbazhagans.S, Indian Drugs., 2004; 41, 284 – 289.
  11. T. Radhakrishna, D. Sreenivas RaoAnd G. Om Reddyre, Determination Of Pioglitazone Hydrochloride In Bulk And Pharmaceutical Formulations By Hplc And Mekc Methods,
  12. S.Sayad,Rp-Hplc Method Development For Determination Of Pioglitazone Hydrochloride From Tablets
  13. R.T. Sane, Simultaneous Determination Of Pioglitazone And Glimepiride By High-Performance Liquid Chromatography
  14. D.Srinivasulu,Developmeny And Validation Of Pioglitazon In Dosage Form,International Journal Of Chemistry Research,Vol.1,Issu.1,2009.
  15. D.Boopathy,B.Praveen Kumar Reddy,Method Development And Validation Of
  16. Simaltanious Determination Of Pioglitazon And Glimepiride By Rp-Hplc
  17. Ching-Ling Cheng. D, Determination Of Metformin By Hplc With Spectrophotometer Detection.
  18. Arayne Ms,Sultana N, Zuberi Mh, Development And Validation Of Rp_Hplc Method For Analysis Of Metformin, Pak J Pharm Sci. 2006 Jul;19(3):231-5
  19. Parisa Gazerani, Determination Of Metformin In Human Plasma By Hplc .
  20. Ceren Yardimci, Method Development And Validation For The Simultaneous Determination Of Rosiglitazone And Metformin In Pharmaceutical Preparations By Capillary Zone Electrophoresis.
  21. K.SLakshmi, T. Rajesh, ShrinivasSharma, Simultaneous determination of pioglitazone and metformin in dosage form, imternational journal of pharmacy and pharmaceutical science ,vol. 1,issue 2,oct-dec.2009
  22. P. Sahoo, R. Sharma, S. Chaturvedi, Simultaneous Estimation Of Metformin Hydrochloride And Pioglitazone Hydrochloride By Rphplc Method From Combined Tablet Dosage Form.(Short Communication)(Reverse-Phase High Performance Liquid Chromatography)(Clinical Report), Indian Journal Of Pharmaceutical Sciences.
  23.  http://www.drugbank.ca/drugs/db06751
  24. Satish A Patel, Kalpesh N, Mayank R. A Novel Validated Simultaneous Equations Method for Simultaneous Estimation of Omeprazole and Ondansetron in Bulk and Pharmaceutical Preparation. Int J Pharm Sci Rev Res. 2022;74(1):150–154.
  25. Lal B, Jaimini M, Kapoor D. Devesh Kapoor: Development and Validation of an RPHPLC Method For the Simultaneous Estimation of Amoxicillin, Omeprazole, And Tinidazole in Fixed-Dose Combinations. Journal Of Drug Delivery & Therapeutics. 2021;11(5-S):57-62.
  26. Shaikh Z, Ahad A. Showkat Patel and Maqdoom Farooqui; Development & Validation of HPLC Method For Simultaneous Estimation of Drotaverine and Omeprazole. International Journal of Chemtech Research. 2020;(1):1–10.
  27. Makhani AA, Devhare LD. Development and Validation of Analytical Methods for Drotaverine and Nimesulide Combination. Research Chronicle in Health Sciences. 2017(3):40–44.
  28. Selvadurai MA. Simple And Sensitive Method for The Simultaneous Estimation of Drotaverine Iceland Aceclofenac Using Rp-Hplc.Journal of Pharma Sci Drug Des.2014(1): 1-3.

Reference

  1. Beckett H., Stenlake J.B., “Practical Pharmaceutical Chemistry.”, C.B.S. Publications, 4th Edition, 1
  2. Vijay Malik, “Drugs And Cosmetics Act.”, Eastern Book Company Lucknow, 16th Edition, 5.
  3. Willard H. H., Merit L.L., Dean F.A., And Settle F.A., “Instrumental Methods Of Analysis.”, C.B. S. Publishers, New Delhi, 7th Edition, 2002, 580-613
  4. Skoog D.A., Holler F.J., Nieman T.A., “ Principles Of Instrumental Analysis.”, 5th Edition, 2005, 733-738.
  5. Sharma b.k., “instrumental methods of chemical analysis.”, goel publishing house, meerut, 24th edition, 2005, c-210-215..
  6. Michael e., schartz s., krull., “analytical method development and validation.”, 2004, 25-46
  7. Lloyd R. Snyder., Joseph J. Kirkland., Joseph L. Glajesh., “Practical Hplc Method Development.”, 2nd Edition, 1997, 1-14.
  8. Cims – 2006, Current Index Of Medical Specialities, Pp.172 – 174.
  9. Alfred Goodman Gilman, Joel G.Hardaman, Lee E.Limbird, 2001, Goodman Gilman’s The Pharmacological Bases Of Therapeutics 10th Edn., Pp. 994 – 995.
  10. Manoj, Shanmugapandiyan.P And Anbazhagans.S, Indian Drugs., 2004; 41, 284 – 289.
  11. T. Radhakrishna, D. Sreenivas RaoAnd G. Om Reddyre, Determination Of Pioglitazone Hydrochloride In Bulk And Pharmaceutical Formulations By Hplc And Mekc Methods,
  12. S.Sayad,Rp-Hplc Method Development For Determination Of Pioglitazone Hydrochloride From Tablets
  13. R.T. Sane, Simultaneous Determination Of Pioglitazone And Glimepiride By High-Performance Liquid Chromatography
  14. D.Srinivasulu,Developmeny And Validation Of Pioglitazon In Dosage Form,International Journal Of Chemistry Research,Vol.1,Issu.1,2009.
  15. D.Boopathy,B.Praveen Kumar Reddy,Method Development And Validation Of
  16. Simaltanious Determination Of Pioglitazon And Glimepiride By Rp-Hplc
  17. Ching-Ling Cheng. D, Determination Of Metformin By Hplc With Spectrophotometer Detection.
  18. Arayne Ms,Sultana N, Zuberi Mh, Development And Validation Of Rp_Hplc Method For Analysis Of Metformin, Pak J Pharm Sci. 2006 Jul;19(3):231-5
  19. Parisa Gazerani, Determination Of Metformin In Human Plasma By Hplc .
  20. Ceren Yardimci, Method Development And Validation For The Simultaneous Determination Of Rosiglitazone And Metformin In Pharmaceutical Preparations By Capillary Zone Electrophoresis.
  21. K.SLakshmi, T. Rajesh, ShrinivasSharma, Simultaneous determination of pioglitazone and metformin in dosage form, imternational journal of pharmacy and pharmaceutical science ,vol. 1,issue 2,oct-dec.2009
  22. P. Sahoo, R. Sharma, S. Chaturvedi, Simultaneous Estimation Of Metformin Hydrochloride And Pioglitazone Hydrochloride By Rphplc Method From Combined Tablet Dosage Form.(Short Communication)(Reverse-Phase High Performance Liquid Chromatography)(Clinical Report), Indian Journal Of Pharmaceutical Sciences.
  23.  http://www.drugbank.ca/drugs/db06751
  24. Satish A Patel, Kalpesh N, Mayank R. A Novel Validated Simultaneous Equations Method for Simultaneous Estimation of Omeprazole and Ondansetron in Bulk and Pharmaceutical Preparation. Int J Pharm Sci Rev Res. 2022;74(1):150–154.
  25. Lal B, Jaimini M, Kapoor D. Devesh Kapoor: Development and Validation of an RPHPLC Method For the Simultaneous Estimation of Amoxicillin, Omeprazole, And Tinidazole in Fixed-Dose Combinations. Journal Of Drug Delivery & Therapeutics. 2021;11(5-S):57-62.
  26. Shaikh Z, Ahad A. Showkat Patel and Maqdoom Farooqui; Development & Validation of HPLC Method For Simultaneous Estimation of Drotaverine and Omeprazole. International Journal of Chemtech Research. 2020;(1):1–10.
  27. Makhani AA, Devhare LD. Development and Validation of Analytical Methods for Drotaverine and Nimesulide Combination. Research Chronicle in Health Sciences. 2017(3):40–44.
  28. Selvadurai MA. Simple And Sensitive Method for The Simultaneous Estimation of Drotaverine Iceland Aceclofenac Using Rp-Hplc.Journal of Pharma Sci Drug Des.2014(1): 1-3.

Photo
Shaikh Sabiya
Corresponding author

Shri Pandit Baburao Chaughuke College of Pharmacy, Bhiwandi-421302.

Photo
Suraj Malpani
Co-author

Shri Pandit Baburao Chaughuke College of Pharmacy, Bhiwandi-421302.

Photo
Huzaifa Ansari
Co-author

Shivlingeshwar College of Pharmacy, Almala-413520

Photo
Namra Momin
Co-author

Shivlingeshwar College of Pharmacy, Almala-413520

Photo
Ilsa Momin
Co-author

Shivlingeshwar College of Pharmacy, Almala-413520

Shaikh Sabiya, Suraj Malpani, Huzaifa Ansari, Namra Momin, Ilsa Momin, Simultaneous Determination of Drotaverine and Omeprazole in Combine Dosage Form by RP-HPLC Method, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 1, 2462-2571. https://doi.org/10.5281/zenodo.18350602

More related articles
Herbal Face Mask Formulation Using Chia Seeds for ...
Payal Bisai, Dr. Gyanesh Kumar Sahu, Akansha Sahu, Ujjawal Dubey,...
Role of Artificial Intelligence in Modern Pharmace...
Shubhangi Kandalkar , Pramod Ingale , Poonam Purkar, Shruti Jorw...
Review on Emerging Role of Vitamin K and Riboflavi...
Anusha yadav , Gampa Jyothi , G. Rithwic mani...
Related Articles
MRSA PSOAS Abscess with Spondylodiscitis with MRSA Bacteremia: A Case Report...
Jeffnisha J., Shaiju Dharan, Shahabaz Zailu, Grace Raju...
Mayani Karina*, Basareddy Chandrasekhar, Dhirendra Kumar Tarai, Santosh Kirtane...
Mayani Karina, Santosh Kirtane, Dhirendra Kumar Tarai, Basareddy Chandrasekhar...
Herbal Face Mask Formulation Using Chia Seeds for Skin Nourishment...
Payal Bisai, Dr. Gyanesh Kumar Sahu, Akansha Sahu, Ujjawal Dubey, Rupesh Nirmalkar, Vishal Shrivasta...
More related articles
Herbal Face Mask Formulation Using Chia Seeds for Skin Nourishment...
Payal Bisai, Dr. Gyanesh Kumar Sahu, Akansha Sahu, Ujjawal Dubey, Rupesh Nirmalkar, Vishal Shrivasta...
Role of Artificial Intelligence in Modern Pharmaceutical Formulation Development...
Shubhangi Kandalkar , Pramod Ingale , Poonam Purkar, Shruti Jorwar, Sandhya Desai ...
Herbal Face Mask Formulation Using Chia Seeds for Skin Nourishment...
Payal Bisai, Dr. Gyanesh Kumar Sahu, Akansha Sahu, Ujjawal Dubey, Rupesh Nirmalkar, Vishal Shrivasta...
Role of Artificial Intelligence in Modern Pharmaceutical Formulation Development...
Shubhangi Kandalkar , Pramod Ingale , Poonam Purkar, Shruti Jorwar, Sandhya Desai ...